Medical Pharmacology

Prof. Dr. Ahmet Akıcı

Doctor and researcher Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi İstanbul
COVID-19HypertensionDiabetes MellitusRespiratory Tract InfectionsPregnancy ComplicationsAbnormalities, Drug-Induced
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 6 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Hypertension 5 publications
  • Diabetes Mellitus 3 publications
  • Respiratory Tract Infections 3 publications
  • Pregnancy Complications 2 publications
  • Abnormalities, Drug-Induced 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Pharmacologysaglik.gov.trFrom source
  • InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 6 publications · Model version —From source
  • Publications153 publicationsEurope PMC, OpenAlexFrom source
  • ORCID0000-0002-8593-0818ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1393577/doktorlarimiz.html#ahmet-akicisaglik.gov.tr

Scientific work

Publications on COVID-19

153 publications

  1. Medication adherence in adolescents: physiological, psychosocial, and clinical perspectives

    Naunyn-Schmiedeberg's archives of pharmacology, 2026

    DOI 10.1007/s00210-026-05122-1 PMID 41765948 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  2. Drug-related suicidal events in children and teenagers: Age-stratified insights from FAERS

    Legal Medicine, 2026

    DOI 10.1016/j.legalmed.2026.102800 PMID 41616736 Source: OpenAlex

  3. Population-based trends in antidiabetic medication utilization during the COVID-19 pandemic: results from the PANDUTI-TR study

    Primary health care research & development, 2026

    DOI 10.1017/s1463423626101868 PMID 42830622 Open-access full textSource: Europe PMC

  4. Impact of COVID-19 Restrictions on Nationwide Antipsychotic Use: Results From the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) Study

    Pharmacoepidemiology and drug safety, 2026

    DOI 10.1002/pds.70336 PMID 41609022 Source: Europe PMC

  5. Pregnancy Outcomes Following Maternal Fenofibrate Exposure

    Congenital anomalies, 2026

    DOI 10.1002/cga.70079 PMID 42723444 Open-access full textSource: Europe PMC

  6. An Assessment of Cardiovascular Health Risks in People Working from Home During the Pandemic Period: PANDEV-KALP Study

    DAHUDER Medical Journal, 2026

    DOI 10.56016/dahudermj.1801645 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  7. Drug Exposure Patterns in Dental vs Non-Dental Kounis Syndrome Reports: A Matched Comparative Analysis

    Clinical and Experimental Health Sciences, 2026

    DOI 10.33808/clinexphealthsci.1944700 Open-access full textSource: OpenAlex

  8. Pediatric Stevens–Johnson syndrome and toxic epidermal necrolysis: age-stratified insights from the FAERS database

    Jornal de Pediatria, 2025

    DOI 10.1016/j.jped.2025.101455 PMID 41075813 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  9. Medication-Related Osteonecrosis of the Jaw: Bibliometric Analysis from 2003 to 2023

    Advances in experimental medicine and biology, 2025

    DOI 10.1007/5584_2024_818 PMID 39075305 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  10. Nationwide utilization of antidepressants and anxiolytics during pandemic restrictions: results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study

    Family practice, 2025

    DOI 10.1093/fampra/cmaf072 PMID 40910518 1 citation (Europe PMC) Source: Europe PMC

View all 153 publications